If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Angela Alistar is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Neoplasms Medicine & Life Sciences
Hepatocellular Carcinoma Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Phase II Clinical Trials Medicine & Life Sciences
Critical Pathways Medicine & Life Sciences
Neuroendocrine Tumors Medicine & Life Sciences
Radiosurgery Medicine & Life Sciences
Neoplasm Genes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2012 2018

  • 278 Citations
  • 7 h-Index
  • 9 Article
  • 1 Review article
153 Citations (Scopus)

Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial

KEYNOTE-224 investigators, Jul 1 2018, In : The Lancet Oncology. 19, 7, p. 940-952 13 p.

Research output: Contribution to journalArticle

Hepatocellular Carcinoma
pembrolizumab
sorafenib
Therapeutics
Disease Progression
11 Citations (Scopus)

Circulating mutational portrait of cancer: Manifestation of aggressive clonal events in both early and late stages

Yang, M., Topaloglu, U., Petty, W. J., Pagni, M., Foley, K. L., Grant, S. C., Robinson, M., Bitting, R. L., Thomas, A., Alistar, A., Desnoyers, R. J., Goodman, M., Albright, C., Porosnicu, M., Vatca, M., Qasem, S. A., Deyoung, B., Kytola, V., Nykter, M., Chen, K. & 9 others, Levine, E. A., Staren, E. D., D'Agostino, R. B., Petro, R. M., Blackstock, W., Powell, B. L., Abraham, E., Pasche, B. & Zhang, W., May 4 2017, In : Journal of Hematology and Oncology. 10, 1, 100.

Research output: Contribution to journalArticle

Neoplasms
Mutation
DNA
Mutation Rate
Lung Neoplasms
2 Citations (Scopus)

Gamma Knife radiosurgery for brain metastases from gastrointestinal primary

Page, B. R., Wang, E. C., White, L., McTyre, E., Peiffer, A., Alistar, A., Mu, F., Loganathan, A., Bourland, J. D., Laxton, A. W., Tatter, S. B. & Chan, M. D., Aug 1 2017, In : Journal of Medical Imaging and Radiation Oncology. 61, 4, p. 522-527 6 p.

Research output: Contribution to journalArticle

Radiosurgery
Neoplasm Metastasis
Brain
Gastrointestinal Neoplasms
Nervous System
7 Citations (Scopus)

Mutational landscapes of smoking-related cancers in Caucasians and African Americans: Precision oncology perspectives at Wake Forest Baptist comprehensive Cancer Center

Kytola, V., Topaloglu, U., Miller, L. D., Bitting, R. L., Goodman, M. M., D'Agostino, R. B., Desnoyers, R. J., Albright, C., Yacoub, G., Qasem, S. A., DeYoung, B., Thorsson, V., Shmulevich, I., Yang, M., Shcherban, A., Pagni, M., Liu, L., Nykter, M., Chen, K., Hawkins, G. A. & 17 others, Grant, S. C., Petty, W. J., Alistar, A., Levine, E. A., Staren, E. D., Langefeld, C. D., Miller, V., Singal, G., Petro, R. M., Robinson, M., Blackstock, W., Powell, B. L., Wagner, L. I., Foley, K. L., Abraham, E., Pasche, B. & Zhang, W., Jan 1 2017, In : Theranostics. 7, 11, p. 2914-2923 10 p.

Research output: Contribution to journalArticle

African Americans
Smoking
Neoplasms
Tobacco
Atlases
27 Citations (Scopus)

Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial

Alistar, A., Morris, B. B., Desnoyer, R., Klepin, H. D., Hosseinzadeh, K., Clark, C., Cameron, A., Leyendecker, J., D'Agostino, R., Topaloglu, U., Boteju, L. W., Boteju, A. R., Shorr, R., Zachar, Z., Bingham, P. M., Ahmed, T., Crane, S., Shah, R., Migliano, J. J., Pardee, T. S. & 5 others, Miller, L., Hawkins, G., Jin, G., Zhang, W. & Pasche, B., Jun 1 2017, In : The Lancet Oncology. 18, 6, p. 770-778 9 p.

Research output: Contribution to journalArticle

Pancreatic Neoplasms
Safety
Maximum Tolerated Dose
oxaliplatin
irinotecan